These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 5126065)

  • 1. Sustained release preparations: estimation of plasma concentration in the one compartment open model when release is both immediate and zero order.
    Rodda BE
    Arch Int Pharmacodyn Ther; 1971 Dec; 194(2):290-6. PubMed ID: 5126065
    [No Abstract]   [Full Text] [Related]  

  • 2. Absorption of theophylline from a sustained-release theophylline tablet formulation, Theo-Dur.
    Takagi K; Hasegawa T; Ogura Y; Yamaki K; Suzuki R; Satake T; Imaeda N; Mizukami Y
    Int J Clin Pharmacol Ther Toxicol; 1987 Oct; 25(10):530-5. PubMed ID: 3429057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effectivness prolongation of drugs with special consideration for peroral depot drug forms].
    Hänselmann B; Voigt R
    Pharmazie; 1971 Feb; 26(2):57-77. PubMed ID: 4930108
    [No Abstract]   [Full Text] [Related]  

  • 4. A method of determining the in vivo drug release rate constant of sustained-release preparation.
    Sun H; Chow MS
    Drug Metab Dispos; 1995 Apr; 23(4):449-54. PubMed ID: 7600910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Availability of phenformin in an oral sustained-release form].
    Bramanti G
    Boll Chim Farm; 1973 Jul; 112(7):472-8. PubMed ID: 4765108
    [No Abstract]   [Full Text] [Related]  

  • 6. Absorption of theophylline from conventional and sustained-release tablets.
    Fagerström PO; Mellstrand T; Svedmyr N
    Int J Clin Pharmacol Ther Toxicol; 1981 Mar; 19(3):131-8. PubMed ID: 7228455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absorption and disposition kinetics of lithium carbonate following administration of conventional and controlled release formulations.
    Arancibia A; Corvalan F; Mella F; Concha L
    Int J Clin Pharmacol Ther Toxicol; 1986 May; 24(5):240-5. PubMed ID: 3089949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of oral sustained release clonidine in humans.
    MacGregor TR; Relihan GL; Keirns JJ
    Arzneimittelforschung; 1985; 35(1A):440-6. PubMed ID: 4039184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Biopharmaceutic properties of slow-release codeine phosphate. Drug release from ion exchangers in vitro and in vivo].
    Wildfeuer A; Pfaff G; Lach P
    Arzneimittelforschung; 1994 Jun; 44(6):758-61. PubMed ID: 8053976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A century of dissolution research: from Noyes and Whitney to the biopharmaceutics classification system.
    Dokoumetzidis A; Macheras P
    Int J Pharm; 2006 Sep; 321(1-2):1-11. PubMed ID: 16920290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative pharmacokinetics and relative bioavailability for different preparations of nitrofurantoin.
    Maier-Lenz H; Ringwelski L; Windorfer A
    Arzneimittelforschung; 1979; 29(12):1898-901. PubMed ID: 583541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaceutical and biopharmaceutical quality of a sustained release carbamazepine preparation: a contribution to quality assurance.
    Grunwald F; Czaja J; Düsing R; Schulz HU
    Int J Clin Pharmacol Ther Toxicol; 1992 May; 30(5):160-6. PubMed ID: 1592543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mathematical relationship of in vitro release rates and biological availability of controlled-release nitroglycerin (nitrong).
    Ipsen J
    Curr Ther Res Clin Exp; 1971 Mar; 13(3):193-208. PubMed ID: 4998572
    [No Abstract]   [Full Text] [Related]  

  • 14. [Biological availability of potassium from a sustained release preparation].
    Müller A; Thoma M; Renker H
    Schweiz Med Wochenschr; 1976 Jan; 106(1):27-30. PubMed ID: 1251146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absorption of theophylline from conventional and sustained-release tablets.
    Mellstrand T; Svedmyr N; Fagerström PO
    Eur J Respir Dis Suppl; 1980; 109():54-60. PubMed ID: 6934088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Is the resorption of gram doses of ascorbic acid better from the resorption-delaying preparations? Discussion].
    Kübler W; Westphal J; Brenner G; Siegers CP; Seidel G; Iven H
    Med Klin; 1976 Sep; 71(36):1447-51. PubMed ID: 958110
    [No Abstract]   [Full Text] [Related]  

  • 17. The time to reach steady state after the administration of intravenous bolus, constant infusion, and oral immediate-release and sustained-release preparations.
    Chow MS; Sun H
    Pharmacotherapy; 1990; 10(6):400-5. PubMed ID: 2287561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of an in vitro absorption model system for predicting sustained release of verapamil.
    Neubert R; Fahr F; Mäder C; Lücke L; Fries G; Rostock G
    Arzneimittelforschung; 1992 Sep; 42(9):1098-100. PubMed ID: 1445475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting plasma procainamide concentrations resulting from a sustained-release preparation.
    DiPersio DM; Chow MS
    Clin Pharm; 1985; 4(2):186-91. PubMed ID: 3987218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of controlled release formulations: estimation of the duration of the zero-order absorption and ascertainment of absorption kinetics.
    Macheras P
    Biopharm Drug Dispos; 1991 Apr; 12(3):173-87. PubMed ID: 2059669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.